PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pipeline and approval signals

Search agency notices, approvals, recalls, and regulatory updates from global authorities.

1,114 of 1,114 tracked regulatory updates from 40 agencies and publishers, page 6 of 23.

UKHSAUnited Kingdom6d agoMeasles, mumps and rubella: lab-confirmed cases in England 2026UK Health Security AgencyUKHSAUnited Kingdom6d agoTuberculosis in England, 2026 reportUK Health Security AgencyUKHSAUnited Kingdom6d agoRespiratory syncytial virus (RSV): vaccination for older adultsUK Health Security AgencyUKHSAUnited Kingdom6d agoPneumococcal disease: cases caused by serotypes not covered by PCV13UK Health Security AgencyUKHSAUnited Kingdom6d agoPneumococcal disease: cases caused by serotypes covered by PCV13UK Health Security AgencyUKHSAUnited Kingdom6d agoNotifiable diseases: causative agents reports for 2026UK Health Security AgencyUKHSAUnited Kingdom6d agoAvian influenza: guidance, data and analysisUK Health Security AgencyUKHSAUnited Kingdom6d agoAvian influenza: managing human exposures and sporadic casesUK Health Security AgencyUKHSAUnited KingdomOct 28Meningococcal: the green book chapterUK Health Security AgencyUKHSAUnited KingdomOct 28Infection prevention and control (IPC) in adult social care (ASC)UK Health Security AgencyUKHSAUnited KingdomOct 28Weekly all-cause mortality surveillance: week ending 25 October 2026UK Health Security AgencyUKHSAUnited KingdomOct 27Nipah virus (NiV): biological principlesUK Health Security AgencyUKHSAUnited KingdomOct 27Brucella Reference Unit (BRU)UK Health Security AgencyUKHSAUnited KingdomOct 27Acute respiratory illness in PPDs and the CYPSEUK Health Security AgencyMHRAUnited Kingdom1d agoClinical trials for medicines: Inclusion and Diversity Plan pilot findings publishedMHRA UKMHRAUnited Kingdom1d agoDecision: Orphan registered medicinal productsMHRA UKMHRAUnited Kingdom1d agoGuidance: Herbal medicines granted a traditional herbal registration (THR)MHRA UKMHRAUnited Kingdom2d agoMHRA launches patient safety essay competition for MedSafetyWeekMHRA UKMHRAUnited Kingdom4d agoTriheptanoin (Dojolvi) approved to treat adults and children with a group of rare inherited disordersMHRA UKMHRAUnited Kingdom5d agoMHRA Safety Roundup: October 2026MHRA UKMHRAUnited Kingdom5d agoMHRA approves gene-editing treatment for children aged five and over with serious inherited blood disordersMHRA UKMHRAUnited Kingdom5d agoClass 2 Medicines Recall: Accord-UK Ltd, Lercanidipine Hydrochloride 10mg Film-Coated Tablets, EL(26)A/45MHRA UKMHRAUnited Kingdom6d agoClass 2 Medicines Recall: Advanz Pharma Limited, Mynzepli 40 mg/mL solution for injection in pre-filled syringe, EL(26)A/44MHRA UKMHRAUnited Kingdom6d agoField Safety Notices: 19 to 23 October 2026MHRA UKMHRAUnited KingdomOct 28Access, new active substance and biosimilar work sharing initiativesMHRA UKMHRAUnited KingdomOct 27Decision: Medical devices given exceptional use authorisationsMHRA UKMHRAUnited KingdomOct 27Transparency data: MHRA Performance DataMHRA UKMHRAUnited KingdomOct 27New MHRA research puts needle-free Strep A vaccine within reachMHRA UKMHRAUnited KingdomOct 26#MedSafetyWeek (2 to 8 November 2026): Don't ignore suspected side effects, report them! Updates to the Yellow Card website and appMHRA UKMHRAUnited KingdomOct 26Class 2 Medicines Recall: Xeal Pharma, Clopidogrel Oral Liquids (all strengths), EL(26)A/43MHRA UKMHRAUnited KingdomOct 23MHRA approves deuruxolitinib (Leqselvi) to treat severe alopecia areata in adultsMHRA UKMHRAUnited KingdomOct 23MHRA approves new oral treatment for moderate to severe plaque psoriasisMHRA UKMHRAUnited KingdomOct 22Guidance: COVID-19 test validation approved productsMHRA UKMHRAUnited KingdomOct 22Opportunities for patients and the public to be involved in the work of the MHRAMHRA UKMHRAUnited KingdomOct 21Government confirms indefinite recognition of CE marked medical devicesMHRA UKMHRAUnited KingdomOct 21Medical devices regulations: targeted consultation on the indefinite recognition of CE marked devicesMHRA UKMHRAUnited KingdomOct 20Decision: Parallel import licences granted in 2026MHRA UKMHRAUnited KingdomOct 20Decision: Marketing authorisations granted in 2026MHRA UKMHRAUnited KingdomOct 20IXCHIQ Chikungunya vaccine: UK marketing authorisation withdrawn following safety reviewMHRA UKMHRAUnited KingdomOct 19MHRA authorises plozasiran (Redemplo) for adults with familial chylomicronaemia syndromeMHRA UKMHRAUnited KingdomOct 19UK regulator brings new AI and MedTech agenda to AdvaMedMHRA UKMHRAUnited KingdomOct 19Field Safety Notices: 5 to 9 October 2026MHRA UKMHRAUnited KingdomOct 19Field Safety Notices: 12 to 16 October 2026MHRA UKMHRAUnited KingdomOct 19Consultation on schools holding Adrenaline Nasal Sprays for anaphylaxisMHRA UKMHRAUnited KingdomOct 19MHRA consults on proposals to allow schools to keep spare adrenaline nasal sprays on siteMHRA UKMHRAUnited KingdomOct 16Nova Biomedical StatStrip ketone test strips: risk of disruption to blood ketone testing due to quality-control failures and supply interruption DSI/2026/013MHRA UKMHRAUnited KingdomOct 16Field Safety Notices: 27 to 31 January 2025MHRA UKMHRAUnited KingdomOct 16Register medical devices to place on the marketMHRA UKMHRAUnited KingdomOct 15Counterfeit weight loss pens worth Β£2 million seized by MHRA and West Midlands PoliceMHRA UKMHRAUnited KingdomOct 15Decision: Suspended and revoked licences and registrations for manufacturers and wholesalers of medicines and ingredientsMHRA UK